-
LZTR1 functions as a two‐hit tumor suppressor in childhood acute lymphoblastic leukemia
Adeline A. Bonnard,
Aurélie Caye‐Eude,
Chloé Arfeuille,
Séverine Drunat,
Anna Dehler,
Fabio D. Steffen,
Elodie Lainey,
Damien Bodet,
Claire Freycon,
Catherine Paillard,
Pauline Simon,
Arnaud Petit,
Cécile Pochon,
Jean‐Hugues Dalle,
Nastassja Scheidegger,
Beat Bornhauser,
André Baruchel,
Marion Strullu,
Yoann Vial,
Hélène Cavé
HemaSphere
· Гематология
· 2026-11-19
-
Fixed‐duration glofitamab in patients with relapsed or refractory follicular lymphoma: Results from a Phase 1/2 study
Franck Morschhauser,
Lorenzo Falchi,
Carmelo Carlo‐Stella,
Emmanuel Bachy,
Michael Crump,
Fritz Offner,
Martin Hutchings,
Anna Sureda,
Krish Patel,
Mark Hertzberg,
Sirpa Leppa,
Sonia Gonzalez de Villambrosia,
Estefania Mulvihill,
James Relf,
Alessia Bottos,
Vanessa Breton,
Pauline Baumlin,
Kathryn Humphrey,
Linda Lundberg,
Michael Dickinson
HemaSphere
· Гематология
· 2026-11-17
Abstract More effective options are needed to personalize treatment for relapsed/refractory (R/R) follicular lymphoma (FL) by balancing efficacy, safety, and accessibility. We report efficacy and safety of glofitamab, a CD20xCD3 T‐cell...
-
EHA Guidelines for the use and reporting of patient‐reported outcomes in clinical trials of classical Philadelphia chromosome‐negative myeloproliferative neoplasms
Esther Natalie Oliva,
Tatyana Ionova,
Marta Sobas,
Peter Loeffelhardt,
Edward Laane,
Sam Salek
HemaSphere
· Гематология
· 2026-11-17
Abstract Patient‐reported outcome measures (PROMs) are increasingly used in clinical trials of classical Philadelphia chromosome‐negative myeloproliferative neoplasms (Ph‐negative MPNs; myelofibrosis [MF], polycythemia vera [PV], and...
-
Modulation of the RNA‐sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia
Nadia El Khawanky,
Tatiana Nedelko,
Giada Mandracci,
Yunus Barth,
Yuan Jiang,
Kai Wang,
Marc Rosenbaum,
Christin Weiß,
Christoph Geisenberger,
Stefan Enßle,
Ana M. Gómez Martínez,
Sascha Göttert,
Noomen Hamed,
Julius C. Fischer,
Jürgen Ruland,
Dirk H. Busch,
Hendrik Poeck,
Katharina S. Götze,
Anna L. Illert,
Florian Bassermann,
Simon M. Heidegger
HemaSphere
· Гематология
· 2026-11-11
Abstract DNA hypomethylating agents (HMAs) such as 5‐azacytidine (5‐AZA) are a cornerstone in the treatment of acute myeloid leukemia (AML), but development of resistance represents a major clinical challenge. Apart from epigenetic...
-
Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome
Bhavisha A. Patel,
Ajoy Dias,
Daniele Avila,
Tonya Jenkins,
Lisa Duncan,
Roxanne Merkel,
Alice Fike,
Julie Onyechi,
Xingmin Feng,
Fernanda Gutierrez‐Rodrigues,
Ivana Darden,
Shanni Liu,
Benjamin Turturice,
Jennifer Hendricks,
Erin Flannelly,
Kristen Cole,
Kanak Parmar,
Ruba Shalhoub,
Colin O. Wu,
Jennifer Lotter,
Boeui Kang,
Sachiko Kajigaya,
Corina Gonzalez,
Chuanfeng Wu,
Marcela A. Ferrada,
Jennifer Cuellar‐Rodriguez,
Mary Czech,
Katherine R. Calvo,
Richard W. Child
HemaSphere
· Гематология
· 2026-11-10
-
Impact of venetoclax‐based therapies on CLL‐associated autoimmune cytopenias: A retrospective study conducted by ERIC
Candida Vitale,
Thomas Chatzikonstantinou,
Christina Papangelou,
Francesca Perutelli,
Maria Chiara Montalbano,
Giulia Bondielli,
Elia Boccellato,
Salem Alshemmari,
Francesco Angotzi,
Miguel Arguello‐Tomas,
Tomas Arpas,
Sandra Bašić‐Kinda,
Sotiria Besikli‐Dimou,
Łukasz Bołkun,
Tomasz Buczek,
Aleksandra Butrym,
Katherine Chapis,
Sofia Chatzileontiadou,
Rosa Collado,
Raul Cordoba Mascuñano,
Lorenzo De Paoli,
Marina Deodato,
Maria Dimou,
David Donaldson,
Joanna Drozd‐Sokołows
HemaSphere
· Гематология
· 2026-11-06
Abstract The impact of venetoclax‐based therapies on autoimmune cytopenias (AIC) in patients with chronic lymphocytic leukemia (CLL) is largely unknown. This study aimed to evaluate preexisting and treatment‐emergent AIC in patients...
-
Differential recovery of macrophage iron deficiency by oral iron formulations determines inflammation and autocrine hepcidin production in iron‐deficiency anemia
Ada Antypiuk,
Michela Asperti,
Richa Sharma,
Shobana Navaneethabalakrishnan,
Navdeep Jhita,
Quentinn Pearce,
James E. Cox,
Elisa Brilli,
Germano Tarantino,
Francesca Vinchi
HemaSphere
· Гематология
· 2026-11-06
Abstract Exposure of macrophages to iron has been implicated in sterile inflammation through reactive oxygen species (ROS)‐dependent cell pro‐inflammatory activation. Here, we compare the effect of the commonly used oral iron salt, iron...
-
Management of advanced mycosis fungoides and Sézary Syndrome: International Recommendations for systemic treatments and allogeneic hematopoietic cell transplantation from the European Hematology Association, the EORTC Cutaneous Lymphoma Tumours Group, the International Society for Cutaneous Lymphoma, and the Lymphoma Working Party of the EBMT
Francesco Onida,
Pietro Quaglino,
Julia Scarisbrick,
Anna Sureda,
Emmilia Hodak,
Evangelia Papadavid,
Silvia Alberti‐Violetti,
Martine Bagot,
Lorenzo Cerroni,
Amrita Goyal‐O'Leary,
Rudolf Stadler,
Rein Willemze,
Jasmine Zain,
Marco Ardigò,
Emilio Berti,
Adèle de Masson,
Rafael F. Duarte,
Francine Foss,
Eva González‐Barca,
Joan Guitart,
Pablo Ortiz‐Romero,
Alessandro Pileri,
Pierluigi Porcu,
Henry M. Prince,
Sima Rozati,
Serena Rupoli,
Maarten H. Vermeer,
Sean Whittaker
HemaSphere
· Гематология
· 2026-11-05
Abstract Advanced mycosis fungoides (MF) and Sézary syndrome (SS) are the most aggressive forms of cutaneous T‐cell lymphoma and remain associated with a poor prognosis and heterogeneous therapeutic approaches. Recent advances,...
-
How we treat venous thromboembolism in pregnancy in a resource‐limited setting
Theresa Nwagha,
Helen Okoye,
Megan Kell,
Edeghonghon Olayemi,
Imelda Bates,
Jecko Thachil
HemaSphere
· Гематология
· 2026-11-04
-
Lineage switch in childhood leukemia
Katharina Daugs,
Anna Prazmo,
Anindita Roy,
Arndt Borkhardt
HemaSphere
· Гематология
· 2026-11-04
Abstract Lineage switch (LS) is a rare but aggressive immunophenotypic transformation of acute leukemia associated with limited therapeutic options and poor clinical outcome. Although LS has been increasingly recognized in the era of...
-
Maladaptive DNA damage responses impair CD8 T‐cell fitness after allogeneic stem cell transplantation
Tobias Ronny Haage,
Domenica Saul,
Romy Böttcher‐Loschinski,
Martin Böttcher,
Simon Völkl,
Andreas Mackensen,
Matthias Leisegang,
Maurice Michel,
Denise Walther,
Dimitrios Mougiakakos
HemaSphere
· Гематология
· 2026-11-04
-
Chimeric antigen receptor T‐cell therapy as a cure for large B‐cell lymphoma
Danielle S. Wallace,
Yashashree Gupta,
Carla Casulo,
Wendy Osborne
HemaSphere
· Гематология
· 2026-11-03
Abstract Large B‐cell lymphoma (LBCL) is cured in most patients with first‐line chemoimmunotherapy; however, 30%–40% of patients will have relapsed or refractory (R/R) disease. Of these patients, those with refractory or early relapsed...
-
Low tumor burden follicular lymphoma: The state of the art
Greg Hapgood,
Joshua Tobin,
Robert Kridel,
Brad Kahl
HemaSphere
· Гематология
· 2026-11-03
Abstract Follicular lymphoma (FL) is the commonest indolent non‐Hodgkin lymphoma. Most patients present with advanced‐stage and are stratified by the Groupe d'Etude des Lymphomes Folliculaires (GELF) criteria into high or low tumor...
-
Improved multistate survival in younger AML patients over time
Sjoerd J. F. Hermans,
Jurjen Versluis,
Gert J. Ossenkoppele,
Edo Vellenga,
Thomas Pabst,
Leo F. Verdonck,
Johan Maertens,
Dimitri Breems,
Markus G. Manz,
Bart Biemond,
Jürgen Kuball,
Marinus van Marwijk Kooy,
Mojca Jongen‐Lavrencic,
Peter C. Huijgens,
Jakob Passweg,
Bjørn T. Gjertsen,
Soren Lehmann,
Patrycja Gradowska,
Berna Beverloo,
Peter Valk,
Gerwin Huls,
Liesbeth C. de Wreede,
Bob Löwenberg,
Jan J. Cornelissen
HemaSphere
· Гематология
· 2026-11-03
Abstract Over the last three decades, HOVON‐SAKK has performed six randomized controlled trials (RCTs) in newly diagnosed younger adults with acute myeloid leukemia (AML). While overall survival (OS) improved over time, no OS benefit...
-
Infections and their determinants in patients with non‐Hodgkin lymphoma receiving bispecific T‐cell antibodies: Results from an international multicenter cohort study
Zainab Shahid,
Michelle Okwali,
Ashlee Joseph,
David Nemirovsky,
Derkach Andriy,
Clare Grieve,
Rafaella Tringale,
Reid Merryman,
Aaron Zou,
Silvia Ferrari,
Monica Rondi,
Sean Harrop,
Divya Somasekharannair,
Jennifer Crombie,
Gilles Salles,
Giuseppe Gritti,
Michael Dickinson,
Lorenzo Falchi
HemaSphere
· Гематология
· 2026-11-01
-
Issue Information
HemaSphere
· Гематология
· 2026-10-29
-
Emergency hematopoiesis in sepsis: A pathway to myeloid clonal expansion
Olisaemeka Ogbue,
Tariq Kewan,
Serhan Unlu,
Kartik Lakhotiya,
Omar Mehkri,
Rayna Ellison,
Francois Fadell,
Felipe de Almeida Sartori,
Asfand Yar Cheema,
Mark Orland,
Arda Durmaz,
Zachary Brady,
Jennifer VanOudenhove,
Abhay Singh,
Valeria Visconte,
Lourdes Mendez,
David S. Bosler,
Stephanie Halene,
Mohammed J. Al‐Jaghbeer,
Abhijit Duggal,
Jaroslaw P. Maciejewski,
Carmelo Gurnari
HemaSphere
· Гематология
· 2026-10-29